Cargando…
Scapula chondrosarcoma: A case report
RATIONALE: Chondrosarcoma is a malignant mesenchymal tumor originating from cartilage. The pelvis, ribs, femur, and humerus are the most frequently affected sites, and scapula involvement is relatively rare. The aim of the present study was to report a case of chondrosarcoma in the scapula. PATIENT...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831252/ https://www.ncbi.nlm.nih.gov/pubmed/31027132 http://dx.doi.org/10.1097/MD.0000000000015388 |
_version_ | 1783465926057787392 |
---|---|
author | Qiang, Shuai Ma, Xin-Nan Wang, Hong-Wei Lv, Song-Cen |
author_facet | Qiang, Shuai Ma, Xin-Nan Wang, Hong-Wei Lv, Song-Cen |
author_sort | Qiang, Shuai |
collection | PubMed |
description | RATIONALE: Chondrosarcoma is a malignant mesenchymal tumor originating from cartilage. The pelvis, ribs, femur, and humerus are the most frequently affected sites, and scapula involvement is relatively rare. The aim of the present study was to report a case of chondrosarcoma in the scapula. PATIENT CONCERNS: A 42-year-old woman presented with a 3-month history of a painful mass in the right scapula. DIAGNOSES AND INTERVENTION: The patient underwent tumor resection. The post-operative pathological diagnosis was scapula chondrosarcoma. OUTCOMES: Following resection, the patient continued to receive routine follow-up care. There was no recurrence or tumor metastasis at a follow-up of 5 years. CONCLUSIONS: Surgery remains the primary therapy for chondrosarcoma. One of the greatest challenges in the management of chondrosarcoma is to accurately assess tumor grade before surgical intervention. Chemotherapy and radiotherapy have been applied without success. Chemo- and radioresistance have been examined beyond classic phenotypic properties to identify more efficient therapeutic strategies. Therefore, development of future novel therapies is contingent upon elucidating the molecular mechanisms of chondrosarcoma. |
format | Online Article Text |
id | pubmed-6831252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-68312522019-11-19 Scapula chondrosarcoma: A case report Qiang, Shuai Ma, Xin-Nan Wang, Hong-Wei Lv, Song-Cen Medicine (Baltimore) 5700 RATIONALE: Chondrosarcoma is a malignant mesenchymal tumor originating from cartilage. The pelvis, ribs, femur, and humerus are the most frequently affected sites, and scapula involvement is relatively rare. The aim of the present study was to report a case of chondrosarcoma in the scapula. PATIENT CONCERNS: A 42-year-old woman presented with a 3-month history of a painful mass in the right scapula. DIAGNOSES AND INTERVENTION: The patient underwent tumor resection. The post-operative pathological diagnosis was scapula chondrosarcoma. OUTCOMES: Following resection, the patient continued to receive routine follow-up care. There was no recurrence or tumor metastasis at a follow-up of 5 years. CONCLUSIONS: Surgery remains the primary therapy for chondrosarcoma. One of the greatest challenges in the management of chondrosarcoma is to accurately assess tumor grade before surgical intervention. Chemotherapy and radiotherapy have been applied without success. Chemo- and radioresistance have been examined beyond classic phenotypic properties to identify more efficient therapeutic strategies. Therefore, development of future novel therapies is contingent upon elucidating the molecular mechanisms of chondrosarcoma. Wolters Kluwer Health 2019-04-26 /pmc/articles/PMC6831252/ /pubmed/31027132 http://dx.doi.org/10.1097/MD.0000000000015388 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 5700 Qiang, Shuai Ma, Xin-Nan Wang, Hong-Wei Lv, Song-Cen Scapula chondrosarcoma: A case report |
title | Scapula chondrosarcoma: A case report |
title_full | Scapula chondrosarcoma: A case report |
title_fullStr | Scapula chondrosarcoma: A case report |
title_full_unstemmed | Scapula chondrosarcoma: A case report |
title_short | Scapula chondrosarcoma: A case report |
title_sort | scapula chondrosarcoma: a case report |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831252/ https://www.ncbi.nlm.nih.gov/pubmed/31027132 http://dx.doi.org/10.1097/MD.0000000000015388 |
work_keys_str_mv | AT qiangshuai scapulachondrosarcomaacasereport AT maxinnan scapulachondrosarcomaacasereport AT wanghongwei scapulachondrosarcomaacasereport AT lvsongcen scapulachondrosarcomaacasereport |